DOI: 10.36347/sjams.2019.v07i08.022

Pages: 2735-2738

Kidney disease is ranked 3rd amongst life threatening diseases in India, after cancer and heart disease. Anaemia affects patients with renal impairment and is common in both pre-dialysis and on dialysis patients, leading to decreased exercise tolerance, reduced life quality and additional risk factors for early death. 25 cases admitted in kidney unit at a tertiary care centre were randomly selected for this study between May 2018 to August 2018. All patients were examined and investigated thoroughly as per proforma. The most common type of anaemia was microcytic hypochromic type in 18 patients (72 %), normocytic normochromic with 2 patients(8%), macrocytic in 2 patients(8%) and 3 patients(12%) had haemoglobin overshoot due to treatment &1(4/) had normal Hb. Most common symptoms were facial puffiness, easy fatigability and pedal edema. Most common associated diseases were hypertension, diabetes mellitus, ischaemic heart disease and dyslipidemia. CKD is more common in older age groups. Anaemia is most common complication of CKD and severity of anaemia increases as CKD worsens. In the present study, all patients had anaemia. Both MHD and medical line treatment with EPO have beneficial effect on Hb levels.